On June 6, 2011 the AMDA will host a webinar on Respiratory Muscle Strength Training in Pompe diseaseA rare genetic disease in which the body cannot properly break down glycogen, leading to buildup that damages muscles and can affect breathing and, in some cases, the heart. at 12:00pm
March 18, 2011
PCMA of Texas hosting “Pull for Pompe” Fundraiser
PCMA of Texas invites you to enjoy a day of family fun benefitting Acid Maltase Deficiency, also known as Pompe
Cincinnati Children’s Hospital is conducting a study about the speech, language and swallowing problems in infants and children with Pompe
Webinar Details Title: Genzyme’s Next Generation Pompe Treatment: Clinical Development Overview Date: Thursday, February 3, 2011 Speakers:Edward Kaye, MDAlison McVie-Wylie,
January 31, 2011
AMDA Webinar on Genzyme’s Next Generation Pompe Treatment: Clinical Development Overview
The AMDA is hosting yet another webinar for the Pompe community on Feb 3, 2011. Title: Genzyme’s Next Generation Pompe
CAMBRIDGE, Mass.—Genzyme Corp. today announced that it will build an additional manufacturing plant in Geel, Belgium, to support the long-term
Jan. 19, 2011—BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has initiated a Phase 1/2 trial for BMN 701,
January 1, 2011
2010 AMDA Research Grant Awarded to Dr. Andrea Amalfitano
In 2010 the AMDA solicited grant applications from researchers around the world. After careful consideration and consultation with our Scientific
December 13, 2010
BMN-701: Potentially More Effective Treatment Option For Pompe
Webinar Details Title: BMN-701: Potentially more effective treatment option for Pompe Date: Monday, December 13, 2010 Speaker: Barbara Wuebbels, BioMarinJon
